Metadata Search Funding Data Link References Status API Help
Facet browsing currently unavailable
Page 1 of 2762 results
Sort by: relevance publication year
Showing results for ISSN matching 1525-7304

Phase 1B Study of Momelotinib Combined With Trametinib in Metastatic, Kirsten Rat Sarcoma Viral Oncogene Homolog-Mutated Non–Small-Cell Lung Cancer After Platinum-Based Chemotherapy Treatment Failure

JOURNAL ARTICLE published November 2018 in Clinical Lung Cancer

Authors: David A. Barbie | Alexander Spira | Karen Kelly | Rita Humeniuk | Jun Kawashima | Shengchun Kong | Marianna Koczywas

https://doi.org/10.1016/j.cllc.2018.07.004 Actions

Treatment Monitoring Program for Implementation of Adherence to Second-Line Erlotinib for Advanced Non–Small-Cell Lung Cancer

JOURNAL ARTICLE published July 2013 in Clinical Lung Cancer

Authors: Vittorio Gebbia | Massimo Bellavia | Giuseppe Luigi Banna | Paolo Russo | Francesco Ferraù | Paolo Tralongo | Nicolò Borsellino

https://doi.org/10.1016/j.cllc.2012.11.007 Actions

Clinical Behavior of Combined Versus Pure High-Grade Neuroendocrine Carcinoma

JOURNAL ARTICLE published January 2022 in Clinical Lung Cancer

Authors: Yoshinori Handa | Yasuhiro Tsutani | Masaoki Ito | Yoshihiro Miyata | Hidenori Mukaida | Mayumi Kaneko | Yukio Takeshima | Morihito Okada

https://doi.org/10.1016/j.cllc.2021.06.010 Actions

Current Perspectives with Pemetrexed in Thoracic Malignancies

JOURNAL ARTICLE published April 2004 in Clinical Lung Cancer

Authors: Chandra P. Belani

https://doi.org/10.3816/clc.2004.s.001 Actions

2003 Highlights From: XII European Cancer Conference Copenhagen, Denmark September 21-25, 2003

JOURNAL ARTICLE published January 2004 in Clinical Lung Cancer

Authors: Angelia D. Gibson | David Lee | Kavita Maung | Preeta Tyagia | Chandra P. Belani | Vinay K. Jain | Sakkaraiappan Ramalingam | Rafael Rosell

https://doi.org/10.1016/s1525-7304(11)70339-4 Actions

Tirapazamine with Cisplatin and Vinorelbine in Patients with Advanced Non–Small-Cell Lung Cancer: A Phase I/II Study

JOURNAL ARTICLE published April 2005 in Clinical Lung Cancer

Authors: Michel Gatineau | Olivier Rixe | Thierry Le Chevalier

https://doi.org/10.3816/clc.2005.n.008 Actions

Proportion of Non–Small-Cell Lung Cancer Patients that Would Have Been Eligible for Lung Cancer Screening

JOURNAL ARTICLE published September 2016 in Clinical Lung Cancer

Authors: Geena X. Wu | Leanne Goldstein | Jae Y. Kim | Dan J. Raz

https://doi.org/10.1016/j.cllc.2016.01.001 Actions

Outcome Differences Between First- and Second-generation EGFR Inhibitors in Advanced EGFR Mutated NSCLC in a Large Population-based Cohort

JOURNAL ARTICLE published September 2019 in Clinical Lung Cancer

Authors: Sally C. Lau | Negar Chooback | Cheryl Ho | Barbara Melosky

https://doi.org/10.1016/j.cllc.2019.05.003 Actions

Rapid Clinical and Radiologic Responses With Larotrectinib Treatment in a Patient With TRK-Fusion–Positive Metastatic Lung Cancer

JOURNAL ARTICLE published March 2020 in Clinical Lung Cancer

Authors: Maximilian Johannes Hochmair | Ulrike Setinek | Dagmar Krenbek | Andreas Fazekas | Oliver Illini | Christoph Weinlinger | Hermann Draxler | Markus Marcher | Arschang Valipour | Leonhard Müllauer | Lucian Beer

https://doi.org/10.1016/j.cllc.2019.11.010 Actions

Long-Term Survival in a Patient with Stage IV Non–Small-Cell Lung Carcinoma After Bone Metastasectomy

JOURNAL ARTICLE published May 2005 in Clinical Lung Cancer

Authors: Anuj K. Agarwala | Nasser H. Hanna

https://doi.org/10.3816/clc.2005.n.017 Actions

STAR-121: A Phase III Randomized Study of Domvanalimab and Zimberelimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Untreated Metastatic Non–Small Cell Lung Cancer With No Actionable Gene Alterations

JOURNAL ARTICLE published January 2024 in Clinical Lung Cancer

Authors: Delvys Rodriguez-Abreu | Joaquim Bosch-Barrera | Jhanelle E. Gray | Myung-Ju Ahn | Melissa Johnson | Xinwei Yu | Saad Mohammad | Xueying Chen | Trever Todd | Jongseok Kim | Martin Reck

https://doi.org/10.1016/j.cllc.2023.12.010 Actions

Phase II Study of Sequential Treatment of Advanced Non–Small-Cell Lung Cancer: Three Cycles of High-Dose Epirubicin Plus Cisplatin Followed by Weekly Vinorelbine

JOURNAL ARTICLE published August 2001 in Clinical Lung Cancer

Authors: Monica Guaraldi | Antonella Marino | Franco Pannuti | Gildino Farabegoli | Andrea Martoni

https://doi.org/10.3816/clc.2001.n.017 Actions

Southwestern Oncology Group Phase II Trial (S0526) of Pemetrexed in Bronchioloalveolar Carcinoma Subtypes of Advanced Adenocarcinoma

JOURNAL ARTICLE published July 2013 in Clinical Lung Cancer

Authors: Derick H.M. Lau | James Moon | Angela M. Davies | Rachel E. Sanborn | Fred R. Hirsch | Wilbur A. Franklin | Janet C. Ruzich | Mary W. Redman | David R. Gandara

https://doi.org/10.1016/j.cllc.2012.12.004 Actions

Editorial Board

JOURNAL ARTICLE published November 2018 in Clinical Lung Cancer

https://doi.org/10.1016/s1525-7304(18)30240-7 Actions

Commentary on “Photodynamic Therapy for Patients with Advanced Non–Small-Cell Carcinoma of the Lung”

JOURNAL ARTICLE published August 2001 in Clinical Lung Cancer

Authors: David Ost

https://doi.org/10.1016/s1525-7304(11)70751-3 Actions

Gemcitabine/Carboplatin in Patients with Metastatic Non–Small-Cell Lung Cancer: Phase II Study of 28-Day and 21-Day Schedules

JOURNAL ARTICLE published November 2005 in Clinical Lung Cancer

Authors: Coleman K. Obasaju | Zhishen Ye | Leslie P. Bloss | Matthew J. Monberg | Rafael E. Curiel

https://doi.org/10.3816/clc.2005.n.037 Actions

Treatment, Rationale, and Study Design of TALISMAN Study: A Randomized Phase II Open-Label Study of Second-line Erlotinib Versus Intermittent Erlotinib Dosing With Docetaxel in the Treatment of Former-Smoker Men Affected by Recurrent Squamous Non–Small-Cell Lung Cancer

JOURNAL ARTICLE published January 2011 in Clinical Lung Cancer

Authors: Cesare Gridelli | Antonio Rossi | Paola Venturino | Filippo de Marinis

https://doi.org/10.3816/clc.2011.n.010 Actions

Asian Thoracic Oncology Research Group (ATORG) Expert Consensus Statement on MET Alterations in NSCLC: Diagnostic and Therapeutic Considerations

JOURNAL ARTICLE published December 2022 in Clinical Lung Cancer

Authors: Myung-Ju Ahn | Marvin Jonne L. Mendoza | Nick Pavlakis | Terufumi Kato | Ross A. Soo | Dong-Wan Kim | Chong Kin Liam | Te-Chun Hsia | Chee Khoon Lee | Thanyanan Reungwetwattana | Sarayut Geater | Oscar Siu Hong Chan | Naiyarat Prasongsook | Benjamin J. Solomon | Thi Thai Hoa Nguyen | Toshiyuki Kozuki | James Chih-Hsin Yang | Yi-Long Wu | Tony Shu Kam Mok | Daniel Shao-Weng Tan | Yasushi Yatabe

https://doi.org/10.1016/j.cllc.2022.07.012 Actions

A Phase II Study of Telisotuzumab Vedotin in Patients With c–MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753)

JOURNAL ARTICLE published May 2021 in Clinical Lung Cancer

Authors: Saiama N. Waqar | Mary W. Redman | Susanne M. Arnold | Fred R. Hirsch | Philip C. Mack | Lawrence H. Schwartz | David R. Gandara | Thomas E. Stinchcombe | Natasha B. Leighl | Suresh S. Ramalingam | Saloni H. Tanna | Ryan S. Raddin | Katherine Minichiello | Jeffrey D. Bradley | Karen Kelly | Roy S. Herbst | Vassiliki A. Papadimitrakopoulou

https://doi.org/10.1016/j.cllc.2020.09.013 Actions

Lung Adenocarcinoma With MUC4 Expression Is Associated With Smoking Status, HER2 Protein Expression, and Poor Prognosis: Clinicopathologic Analysis of 338 Cases

JOURNAL ARTICLE published July 2017 in Clinical Lung Cancer

Authors: Mariyo Rokutan-Kurata | Akihiko Yoshizawa | Shinji Sumiyoshi | Makoto Sonobe | Toshi Menju | Masanobu Momose | Mizuki Koyama | Shohei Shigeto | Masakazu Fujimoto | Meng Zhang | Satoshi Morita | Hiroshi Date | Hironori Haga

https://doi.org/10.1016/j.cllc.2016.11.013 Actions
Feedback: support@crossref.org